Development pipelines in September 2022
The Boston City Properties report dated September 12, 2022 described more than 62 million square feet of laboratory space under construction or proposed across Greater Boston. It contrasted that pipeline with reported existing space in Boston and Cambridge and with the Bay Area’s existing and planned life-science properties.
The comparison separated existing buildings, projects under construction and proposals. Those categories describe different stages of development and help explain the scale of the 2022 pipeline discussion.
Institutions, talent and funding
The article associated the region’s life-science activity with Harvard, MIT, Boston College, teaching hospitals and the development of COVID vaccines. It compared educational and workforce measures across Boston, the Bay Area and other U.S. clusters, including San Diego and New York.
The article discussed first-half 2022 venture funding in Cambridge, Boston and emerging clusters such as Waltham, Watertown and Somerville. Firm-level funding and a particular building’s financing or occupation are separate questions.
Conversions and the regional footprint
The earlier report described office-to-lab conversions and development beyond Kendall Square and the Seaport. Examples included former corporate offices, the former WeWork location near South Station, a proposed drug-manufacturing facility at Suffolk Downs and Eli Lilly’s announced Seaport genetic-medicine research investment.
These were reported projects and market interpretations in 2022, alongside that period’s lease rates, vacancy figures and profitability forecasts. For a premises comparison now, bring the exact address, research activity, systems, transaction and delivery questions to the property conversation.
Historical account: Original Boston City Properties report
